These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12678821)

  • 1. Functionalized S-thio-di- and S-oligosaccharide precursors as templates for novel SLex/a mimetic antimetastatic agents.
    Dey PM; Witczak ZJ
    Mini Rev Med Chem; 2003 Jun; 3(4):271-80. PubMed ID: 12678821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
    Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
    Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
    Maaheimo H; Renkonen R; Turunen JP; Penttilä L; Renkonen O
    Eur J Biochem; 1995 Dec; 234(2):616-25. PubMed ID: 8536711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium.
    Seppo A; Turunen JP; Penttilä L; Keane A; Renkonen O; Renkonen R
    Glycobiology; 1996 Jan; 6(1):65-71. PubMed ID: 8991511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands.
    Renkonen R; Mattila P; Majuri ML; Räbinä J; Toppila S; Renkonen J; Hirvas L; Niittymäki J; Turunen JP; Renkonen O; Paavonen T
    Glycoconj J; 1997 Aug; 14(5):593-600. PubMed ID: 9298692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
    Fuster MM; Brown JR; Wang L; Esko JD
    Cancer Res; 2003 Jun; 63(11):2775-81. PubMed ID: 12782582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination.
    Brown JR; Fuster MM; Li R; Varki N; Glass CA; Esko JD
    Clin Cancer Res; 2006 May; 12(9):2894-901. PubMed ID: 16675586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrosphelide B suppressed metastasis through inhibition of adhesion of sLe(x)/E-selectin molecules.
    Fukami A; Iijima K; Hayashi M; Komiyama K; Omura S
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1065-70. PubMed ID: 11866473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion.
    Turunen JP; Majuri ML; Seppo A; Tiisala S; Paavonen T; Miyasaka M; Lemström K; Penttilä L; Renkonen O; Renkonen R
    J Exp Med; 1995 Oct; 182(4):1133-41. PubMed ID: 7561686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
    Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
    Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialyl Lewis(x) (sLe(x)) and an sLe(x) mimetic, CGP69669A, disrupt E-selectin-dependent leukocyte rolling in vivo.
    Norman KE; Anderson GP; Kolb HC; Ley K; Ernst B
    Blood; 1998 Jan; 91(2):475-83. PubMed ID: 9427700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the E-selectin ligand on NK cells.
    Pinola M; Renkonen R; Majuri ML; Tiisala S; Saksela E
    J Immunol; 1994 Apr; 152(7):3586-94. PubMed ID: 7511652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.
    St Hill CA; Baharo-Hassan D; Farooqui M
    PLoS One; 2011 Jan; 6(1):e16281. PubMed ID: 21283832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyl Lewis X mimics derived from a pharmacophore search are selectin inhibitors with anti-inflammatory activity.
    Rao BN; Anderson MB; Musser JH; Gilbert JH; Schaefer ME; Foxall C; Brandley BK
    J Biol Chem; 1994 Aug; 269(31):19663-6. PubMed ID: 7519598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines.
    Monzavi-Karbassi B; Stanley JS; Hennings L; Jousheghany F; Artaud C; Shaaf S; Kieber-Emmons T
    Int J Cancer; 2007 Mar; 120(6):1179-91. PubMed ID: 17154173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium.
    Fujii Y; Yoshida M; Chien LJ; Kihara K; Kageyama Y; Yasukochi Y; Oshima H
    Urol Int; 2000; 64(3):129-33. PubMed ID: 10859542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-selectin binding by pancreatic tumor cells is inhibited by cancer sera.
    Sawada T; Ho JJ; Chung YS; Sowa M; Kim YS
    Int J Cancer; 1994 Jun; 57(6):901-7. PubMed ID: 7515860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between human eosinophils and neutrophils in the function and expression of sialic acid-containing counterligands for E-selectin.
    Bochner BS; Sterbinsky SA; Bickel CA; Werfel S; Wein M; Newman W
    J Immunol; 1994 Jan; 152(2):774-82. PubMed ID: 7506734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells.
    Martín-Satué M; Marrugat R; Cancelas JA; Blanco J
    Cancer Res; 1998 Apr; 58(7):1544-50. PubMed ID: 9537262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
    Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
    Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.